Joint Disorders in Cystic Fibrosis

Phillips BM , David TJ . Pathogenesis and management of arthropathy in cystic fibrosis. J R Soc Med 1986; 79(Suppl. 12): 44–50.

Hodson ME . Vasculitis and arthropathy in cystic fibrosis. J R Soc Med 1992; 85(Suppl. 19): 38–40.

Johnson S , Knox AJ . Arthropathy in cystic fibrosis. Respir Med 1994; 88: 567–70.

Dickinson CJ . The aetiology of clubbing abd hypertrophic osteoarthropathy. Eur J Clin Invest 1993; 23: 330–8.

Cohen AM , Yulish BS , Wasser KB , Vignos PJ , Jones PK , Sorin SB . Evaluation of pulmonary hypertrophic osteoarthropathy in cystic fibrosis: a comprehensive study. Am J Dis Child 1986; 140: 74–7.

Dixey J , Redington AN , Butler RC The arthropathy of cystic fibrosis. Ann Rheum Dis 1988; 47: 218–23.

Rush PJ , Shore A , Coblentz C , Wilmot D , Corey M , Levison H. The musculoskeletal manifestations of cystic fibrosis. Semin Arth Rheum 1986; 15: 213–25.

Pineda C. Diagnostic imaging in hypertrophic osteoarthropathy. Clin Exp Rheumatol 1992; 10(Suppl. 7): 27–33.

Bourke S , Rooney M , Fitzgerald M , Bresnihan B. Episodic arthropathy in adult cystic fibrosis. QJ Med 1987; NS 64(244): 651–9.

Pertuiset E , Menkes CJ , Lenior G , Jehanne M , Douchain F , Guillot M. Cystic fibrosis arthritis. A report of five cases. Br J Rheum 1992; 31: 535–8.

Wulfraat NM , de Graeff-Meeder ER , Rijkers GT , van der Laag , Kuis W. Prevalence of circulating immune complexes in patients with cystic fibrosis and arthritis. J Pediatr 1994; 125: 374–8.

Schluter G. Ciprofloxacin: toxicologic evaluation of additional safety data. Am J Med 1989; 87(Suppl 5A): 37–9.

Richard DA , Nousia-Arvanitakis S , Sollich V , Hampel B , Sommerauer B , Schaad UB . Prospective, non-blind, randomized comparison of ciprofloxacin (CIP) vs ceftazidime/tobramycin (CTZ/TOB) in the treatment of acute bronchopulmonary exacerbation (ABE) in pediatric and adolescent cystic fibrosis (CF) patients: MRI and ultrasound assessment of safety and comparison of efficacy. Israel J Med Sci 1996; 32(suppl): S257.

Soden M , Tempany E , Bresniham B. Sarcoid arthropathy in cystic fibrosis. Br J Rheumatol 1989; 28: 341–3.

Bengamin CM , Clague RB . Psoriatic or cystic fibrosis arthropathy? Difficulty with diagnosis and management. Br J Rheumatol 1990; 29: 301–2.

Finnegan MJ , Hinchcliffe J , Russell-Jones D Vasculitis complicating cystic fibrosis. QJ Med 1989; NS72: 609–21.

Fradin MS , Kalb RE , Grossman ME . Recurrent vasculitis in cystic fibrosis. Pediatr Dermatol 1987; 4: 108–11.

Garty BZ , Scanlin T , Goldsmith DP , Grunstein M. Cutaneous manifestations of cystic fibrosis: possible role of cryoglobulins. B J Dermatol 1989; 121: 655–8.

Schidlow DV , Panitch HB , Zaeri N , Zenel J , Alpert BE . Purpuric rashes in cystic fibrosis. Am J Dis Child 1989; 143: 1030–2.

Esterly NB . Vasculitis. In: Behrmann RE ed. Nelson's textbook of pediatrics, 14th edn. Philadelphia: WB Saunders, 1992: p 1669.

Fauci AS . The vasculitis syndromes. In: Braunwald E , Isselbacher KJ , Petersdorf RG , Wilson JD , Martin JB , Fauci AS eds. Harrison's principles of internal medicine, 11th edn. New York: McGraw-Hill, 1987: pp 1438–45.

Szer IS . Henoch-Schönlein purpura. Curr Opin Rheumatol 1994; 6: 25–31.

Gross WL , Csernok E. Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheumatol 1995; 7: 11–9.

Schaad UB , Salam MA , Aujard Y Use of fluoroquinolones in paediatrics: consensus report of an International Society of Chemotherapy commission. Prediatr Infect Dis J 1995; 14: 1–9.

Stahlmann R , Forster C , Shakabaei M , Vormann J , Gunther T , Merker H-J. . Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced athropathy. Antimicrob Agents Chemother 1995; 39: 2013–8.

Stahlmann R , Merker H-J , Hinz N Ofloxacin in juvenile non-human primates and rates. Arthropathia and drug plasma concentrations. Arch Toxicol 1991; 64: 193–204.

Lomaestro BM , Bailie GR . Quinolone-cation interactions: a review. Ann Pharmacother 1991; 25: 1249–58.

Kubin R. Safety and efficacy of ciprofloxacin in paediatric patients. Infection 1993; 21: 413–21.

Pertuisset E , Lenoir G , Jehanne M , Douchain F , Guilot M , Menkes CJ . Tolérance articulaire de la pefloxacine et de l'ofloxacine chez les enfants et adolescents atteints de mucoviscidose. Rev Rhum Mal Ostéoartic 1989; 56: 735–40.

Samuelson WM , Pleasants RA , Whitaker MS . Arhropathy secondary to ciprofloxacin in an adult cystic fibrosis patient. Ann Pharmacother 1993; 27: 302–3.

Danisovicova A , Brezina M , Belan S Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. A multicenter survey. Chemotherapy 1994; 40: 209–14.

Schaad UB , Stoupis C , Wedgwood J , Tschaeppeler H , Vock P. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin. Pediatr Infect Dis J 1991; 10: 723–9.

Arico M , Bossi G , Caselli D Long term magnetic resonance survey of cartilage damage in leukemic children treated with fluoroquinolones. Pediatr Infect Dis J 1995; 14: 713–14.

Barland P , Lipstein E. Selection and use of laboratory tests in the rheumatic diseases. Am J Med 1996; 100(Suppl 2A): 16S–23S.

Burnester GR , Daser A , Kamradt T Immunology of reactive athritides. Ann Rev Immunol 1995; 13: 229–50.

Bell JI , O'Hehir RE . Immune mechanisms of disease. In: Weatherall DJ , Ledingham JGG , Warrell DA eds. Oxford Textbook of Medicine, 3rd ed. Oxford: Oxford University Press, 1996: pp 154–65.

Hodson ME , Beldon I , Batten JC . Circulating immune complexes in patients with cystic fibrosis in relation to clinical features. Clin Allergy 1985; 15: 363–70.

Dsis ML , McDonald TL , Colombo JL , Kobayashi RH , Angle CR , Murray S. Circulating immune complexes in cystic fibrosis and their correlation to clinical perameters. Pediatr Res 1986; 20: 385–90.

Wisnieski JJ , Todd EW , Fuller RK Immune complexes and complement abnormalities in patients with cystic fibrosis. Am Rev Respir Dis 1985; 132: 770–7.

Moss RB , Hsu Y-P , Lewiston NJ Association of systemic immune complexes, complement activation and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotozin A with mortality on cystic fibrosis. Am Rev Respir Dis 1986; 133: 648–52.

Manthei U , Taussig LM , Beckerman RC , Strunk RC . Circulating immune complexes in cystic fibrosis. Am Rev Respir Dis 1982; 126: 253–7.

Pitcher-Wilmott RW , Levinsky RJ , Matthew DJ . Circulating soluble immune complexes containing pseudomonas antigens in cystic fibrosis. Arch Dis Child 1982; 57: 577–81.

Church JA , Jordan SG , Keens TG , Wang C-I. . Circulating immune complexes in patients with cystic fibrosis. Chest 1981; 80: 405–11.

Jones MM , Seilheimer DK , Pollack MS , Curry M , Crane MM , Rossen RD . Relationship of hypergammaglobulinemia, circulating immune complexes and histocompatibility antigen profiles in patients with cystic fibrosis. Am Rev Respir Dis 1989; 140: 1636–9.

Abman SH , Ogle JW , Harbeck RJ , Butler-Simon N , Hammond KB , Accurso FJ . Early bacteriologic, immunologic and clinical courses of young infants with cystic fibrosis identified by neonatal screening. J Pediatr 1991; 119: 211–7.

Davis CA , Abramowsky CR , Swinehart G. Circulating immune complexes and the nephropathy of cystic fibrosis. Hum Pathol 1984; 15: 244–7.

Tomashefski JF , Abramowsky CR , Chung-Park M , Wisniewska J , Bruce MC . Immunofluorescence studies of lung tissue in cystic fibrosis. Pediatr Pathol 1992; 12: 313–24.

Stack BHR , Al-Shamma MRR , McSharry C , McCruden L. The role of heat shock proteins in the pathogenesis of arthritis in cystic fibrosis patients. Israel J Med Sci 1996; 32(Suppl): S268.

Dhillon VB Heat shock proteins. Reports on rheumatic diseases. Topical Reviews, series three, Number 5. Chesterfield, UK: Arthritis and Rheumatism Council, 1995.

Jensen E , Hoiby N. Increased level of anti-human hsp60-antibodies precede development of insulin-dependent diabetes in patients with CF. Israel J Med Sci 1996; 32(Suppl): S369.

Lawley TJ , Trank MM . Immune-complex diseases. In: Braunwals E , Isselbacher KJ , Petersdorf RG , Wilson JD , Martin JB , Fauci AS eds. Harrison's principles of inernal medicine. 11th ed. New York: McGraw-Hill, 1987: pp 1414–8.

Pope RM . Rheumatoid arthritis: pathogenesis and early recognition. Am J Med 1996; 100(Suppl 2A): 3S–9S.

Coffey M , Hassan J , Feighery C , Fitzgerald M , Bresnihan B. Rheumatoid factors in cystic fibrosis: association with disease manifestations and recurrent bacterial infections. Clin Exp Immunol 1989; 77: 52–7.

Keogan MT , Callaghan M , Yanni G Spontaneous in vitro production of rheumatoid factor during infectious exacerbation of cystic fibrosis: correlation with circulating immune complex levels. Clin Exp Immunol 1993; 91: 462–6.

Careless DJ , Inman RD . Etiopathogenesis of reactive arthritis and ankylosing spondylitis. Curr Opin Rheumatol 1995; 7: 290–8.

Burmester GR , Daser A , Kamradt T Immunology of reactive arthritides. Annu Rev Immunol 1995; 13: 229–50.

Cid MC . New developments in the pathogenesis of systemic vasculitis. Curr Opin Rheumatol 1996; 8: 1–11.

Calabrese LH , Duna GF . Evaluation and treatment of central nervous system vasculitis. Curr Opin Rheumatol 1995; 7: 37–44.

Exley AR , Bacon PA . Clinical disease activity in systemic vasculitis. Curr Opin Rheumatol 1996; 8: 12–18.

Dubost JJ , Souteyrand P , Sauvezie B. Drug-induced vasculitides. Baillière's Clin Rheumatol 1991; 5: 119–38.